Using immunohistochemical analysis, we counted the numbers of CD4+, CD8+, and Foxp3+ T lymphocytes both in the invasive front and tumor bulk (Figure 1; Supplementary Table 1 ). This evidence concerns the gene CD4 and neoplasm.